Review Article
Current Status and Evaluation of Randomized Clinical Trials of Traditional Chinese Medicine in the Treatment of Cardiovascular Diseases
Table 2
Characteristics of included RCTs on dyslipidemia.
| Researcher | Diagnostic criteria | Sample size | Intervention | Follow-up period | Outcome | Experiment | Control | Experiment | Control |
| Ying Xie | Chinese guidelines on prevention and treatment of dyslipidemia in adults | 69 | 69 | Jiangzhi Tongluo soft capsule + standard treatment | Placebo + standard treatment | 8 weeks | Higher decreased value of TG | Timothy Kwok | LDL ≥ 3.5 mmol/L and <4.9 mmol/L | 85 | 80 | D&G capsule | Placebo | 12 months | Higher decrease in LDL and TC, | Wenhao Jia | TG > 2.3 mmol/L but <6.5 mmol/L),LDL-C < 4.9 mmol/L, total cholesterol (TC) < 7.2 mmol/L | 285(2 experiment groups) | 73 | XZT, XZK | Placebo | 12 weeks | Increases in HDL, decreased TG level | Long Liu | TC ≥ 5.2 mmol/L or TG ≥ 1.65 mmol/L | 60 | 60 | Ganoderma lucidum and sea cucumber extract | Placebo | 45 days | Decreased TC and TG level | Bo Wu | Acupuncture treatment of obesity + TCM syndrome differentiation | 52 | 52 | Acupuncture + tapping | Acupuncture | 3 months | Improved blood lipid level | Syed Kazem Farahmand | Metabolic syndrome, TG ≥ 1.7 mmol/L | 63 | 63 | Dietary regimen + wet cupping treatment | Dietary regimen | 6 weeks | No significant difference in blood lipids |
|
|